HC Wainwright & Co. Reiterates Indaptus Therapeutics (INDP) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 15, 2023, HC Wainwright & Co. reiterated coverage of Indaptus Therapeutics (NASDAQ:INDP) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1347125073-1a34b3e4c1924d6cafc4ef488d33d39f.jpg "What Credit Score Is Needed for a Mortgage?")
